Coformer Screening Using Thermal Analysis Based on Binary Phase Diagrams
ABSTRACT Purpose The advent of cocrystals has demonstrated a growing need for efficient and comprehensive coformer screening in search of better development forms, including salt forms. Here, we investigated a coformer screening system for salts and cocrystals based on binary phase diagrams using th...
Gespeichert in:
Veröffentlicht in: | Pharmaceutical research 2014-08, Vol.31 (8), p.1946-1957 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1957 |
---|---|
container_issue | 8 |
container_start_page | 1946 |
container_title | Pharmaceutical research |
container_volume | 31 |
creator | Yamashita, Hiroyuki Hirakura, Yutaka Yuda, Masamichi Terada, Katsuhide |
description | ABSTRACT
Purpose
The advent of cocrystals has demonstrated a growing need for efficient and comprehensive coformer screening in search of better development forms, including salt forms. Here, we investigated a coformer screening system for salts and cocrystals based on binary phase diagrams using thermal analysis and examined the effectiveness of the method.
Methods
Indomethacin and tenoxicam were used as models of active pharmaceutical ingredients (APIs). Physical mixtures of an API and 42 kinds of coformers were analyzed using Differential Scanning Calorimetry (DSC) and X-ray DSC. We also conducted coformer screening using a conventional slurry method and compared these results with those from the thermal analysis method and previous studies.
Results
Compared with the slurry method, the thermal analysis method was a high-performance screening system, particularly for APIs with low solubility and/or propensity to form solvates. However, this method faced hurdles for screening coformers combined with an API in the presence of kinetic hindrance for salt or cocrystal formation during heating or if there is degradation near the metastable eutectic temperature.
Conclusions
The thermal analysis and slurry methods are considered complementary to each other for coformer screening. Feasibility of the thermal analysis method in drug discovery practice is ensured given its small scale and high throughput. |
doi_str_mv | 10.1007/s11095-014-1296-4 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1559513369</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3421337371</sourcerecordid><originalsourceid>FETCH-LOGICAL-c508t-a5dec670859a2afa5bccd9082e4fb201a2644a9687d6ad79c4c4ae2e71971dd43</originalsourceid><addsrcrecordid>eNp1kE9LAzEQxYMotlY_gBcJeI5msslmc-wftUJBwRa8hTTJtlu6uzVpD_327rJVvHiZgZk3bx4_hG6BPgCl8jECUCUIBU6AqZTwM9QHIROiKP88R30qGSeZ5NBDVzFuKKUZKH6JeowLxjJI-2g6rvM6lD7gDxu8r4pqhRexrfO1D6XZ4mFltsdYRDwy0TtcV3hUVCYc8fu6GeBJYVbBlPEaXeRmG_3NqQ_Q4vlpPp6S2dvL63g4I1bQbE-McN6mkmZCGWZyI5bWOkUz5nm-ZBQMSzk3Ks2kS42TynLLjWdegpLgHE8G6L7z3YX66-DjXm_qQ2gyRg1CKAFJkqpGBZ3KhjrG4HO9C0XZpNZAdctOd-x0w0637HTrfHdyPixL734vfmA1AtYJYrOqVj78ef2v6zc6u3jY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1559513369</pqid></control><display><type>article</type><title>Coformer Screening Using Thermal Analysis Based on Binary Phase Diagrams</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Yamashita, Hiroyuki ; Hirakura, Yutaka ; Yuda, Masamichi ; Terada, Katsuhide</creator><creatorcontrib>Yamashita, Hiroyuki ; Hirakura, Yutaka ; Yuda, Masamichi ; Terada, Katsuhide</creatorcontrib><description>ABSTRACT
Purpose
The advent of cocrystals has demonstrated a growing need for efficient and comprehensive coformer screening in search of better development forms, including salt forms. Here, we investigated a coformer screening system for salts and cocrystals based on binary phase diagrams using thermal analysis and examined the effectiveness of the method.
Methods
Indomethacin and tenoxicam were used as models of active pharmaceutical ingredients (APIs). Physical mixtures of an API and 42 kinds of coformers were analyzed using Differential Scanning Calorimetry (DSC) and X-ray DSC. We also conducted coformer screening using a conventional slurry method and compared these results with those from the thermal analysis method and previous studies.
Results
Compared with the slurry method, the thermal analysis method was a high-performance screening system, particularly for APIs with low solubility and/or propensity to form solvates. However, this method faced hurdles for screening coformers combined with an API in the presence of kinetic hindrance for salt or cocrystal formation during heating or if there is degradation near the metastable eutectic temperature.
Conclusions
The thermal analysis and slurry methods are considered complementary to each other for coformer screening. Feasibility of the thermal analysis method in drug discovery practice is ensured given its small scale and high throughput.</description><identifier>ISSN: 0724-8741</identifier><identifier>EISSN: 1573-904X</identifier><identifier>DOI: 10.1007/s11095-014-1296-4</identifier><identifier>PMID: 24522816</identifier><language>eng</language><publisher>Boston: Springer US</publisher><subject>Biochemistry ; Biomedical and Life Sciences ; Biomedical Engineering and Bioengineering ; Biomedicine ; Differential Thermal Analysis - methods ; Drug Combinations ; Drug Evaluation, Preclinical - methods ; Indomethacin - analysis ; Indomethacin - chemistry ; Medical Law ; Methods ; Pharmaceutical sciences ; Pharmacology/Toxicology ; Pharmacy ; Piroxicam - analogs & derivatives ; Piroxicam - analysis ; Piroxicam - chemistry ; Powder Diffraction - methods ; Research Paper ; X-Ray Diffraction</subject><ispartof>Pharmaceutical research, 2014-08, Vol.31 (8), p.1946-1957</ispartof><rights>Springer Science+Business Media New York 2014</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c508t-a5dec670859a2afa5bccd9082e4fb201a2644a9687d6ad79c4c4ae2e71971dd43</citedby><cites>FETCH-LOGICAL-c508t-a5dec670859a2afa5bccd9082e4fb201a2644a9687d6ad79c4c4ae2e71971dd43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11095-014-1296-4$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11095-014-1296-4$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24522816$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yamashita, Hiroyuki</creatorcontrib><creatorcontrib>Hirakura, Yutaka</creatorcontrib><creatorcontrib>Yuda, Masamichi</creatorcontrib><creatorcontrib>Terada, Katsuhide</creatorcontrib><title>Coformer Screening Using Thermal Analysis Based on Binary Phase Diagrams</title><title>Pharmaceutical research</title><addtitle>Pharm Res</addtitle><addtitle>Pharm Res</addtitle><description>ABSTRACT
Purpose
The advent of cocrystals has demonstrated a growing need for efficient and comprehensive coformer screening in search of better development forms, including salt forms. Here, we investigated a coformer screening system for salts and cocrystals based on binary phase diagrams using thermal analysis and examined the effectiveness of the method.
Methods
Indomethacin and tenoxicam were used as models of active pharmaceutical ingredients (APIs). Physical mixtures of an API and 42 kinds of coformers were analyzed using Differential Scanning Calorimetry (DSC) and X-ray DSC. We also conducted coformer screening using a conventional slurry method and compared these results with those from the thermal analysis method and previous studies.
Results
Compared with the slurry method, the thermal analysis method was a high-performance screening system, particularly for APIs with low solubility and/or propensity to form solvates. However, this method faced hurdles for screening coformers combined with an API in the presence of kinetic hindrance for salt or cocrystal formation during heating or if there is degradation near the metastable eutectic temperature.
Conclusions
The thermal analysis and slurry methods are considered complementary to each other for coformer screening. Feasibility of the thermal analysis method in drug discovery practice is ensured given its small scale and high throughput.</description><subject>Biochemistry</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedical Engineering and Bioengineering</subject><subject>Biomedicine</subject><subject>Differential Thermal Analysis - methods</subject><subject>Drug Combinations</subject><subject>Drug Evaluation, Preclinical - methods</subject><subject>Indomethacin - analysis</subject><subject>Indomethacin - chemistry</subject><subject>Medical Law</subject><subject>Methods</subject><subject>Pharmaceutical sciences</subject><subject>Pharmacology/Toxicology</subject><subject>Pharmacy</subject><subject>Piroxicam - analogs & derivatives</subject><subject>Piroxicam - analysis</subject><subject>Piroxicam - chemistry</subject><subject>Powder Diffraction - methods</subject><subject>Research Paper</subject><subject>X-Ray Diffraction</subject><issn>0724-8741</issn><issn>1573-904X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kE9LAzEQxYMotlY_gBcJeI5msslmc-wftUJBwRa8hTTJtlu6uzVpD_327rJVvHiZgZk3bx4_hG6BPgCl8jECUCUIBU6AqZTwM9QHIROiKP88R30qGSeZ5NBDVzFuKKUZKH6JeowLxjJI-2g6rvM6lD7gDxu8r4pqhRexrfO1D6XZ4mFltsdYRDwy0TtcV3hUVCYc8fu6GeBJYVbBlPEaXeRmG_3NqQ_Q4vlpPp6S2dvL63g4I1bQbE-McN6mkmZCGWZyI5bWOkUz5nm-ZBQMSzk3Ks2kS42TynLLjWdegpLgHE8G6L7z3YX66-DjXm_qQ2gyRg1CKAFJkqpGBZ3KhjrG4HO9C0XZpNZAdctOd-x0w0637HTrfHdyPixL734vfmA1AtYJYrOqVj78ef2v6zc6u3jY</recordid><startdate>20140801</startdate><enddate>20140801</enddate><creator>Yamashita, Hiroyuki</creator><creator>Hirakura, Yutaka</creator><creator>Yuda, Masamichi</creator><creator>Terada, Katsuhide</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20140801</creationdate><title>Coformer Screening Using Thermal Analysis Based on Binary Phase Diagrams</title><author>Yamashita, Hiroyuki ; Hirakura, Yutaka ; Yuda, Masamichi ; Terada, Katsuhide</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c508t-a5dec670859a2afa5bccd9082e4fb201a2644a9687d6ad79c4c4ae2e71971dd43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Biochemistry</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedical Engineering and Bioengineering</topic><topic>Biomedicine</topic><topic>Differential Thermal Analysis - methods</topic><topic>Drug Combinations</topic><topic>Drug Evaluation, Preclinical - methods</topic><topic>Indomethacin - analysis</topic><topic>Indomethacin - chemistry</topic><topic>Medical Law</topic><topic>Methods</topic><topic>Pharmaceutical sciences</topic><topic>Pharmacology/Toxicology</topic><topic>Pharmacy</topic><topic>Piroxicam - analogs & derivatives</topic><topic>Piroxicam - analysis</topic><topic>Piroxicam - chemistry</topic><topic>Powder Diffraction - methods</topic><topic>Research Paper</topic><topic>X-Ray Diffraction</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yamashita, Hiroyuki</creatorcontrib><creatorcontrib>Hirakura, Yutaka</creatorcontrib><creatorcontrib>Yuda, Masamichi</creatorcontrib><creatorcontrib>Terada, Katsuhide</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Pharmaceutical research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yamashita, Hiroyuki</au><au>Hirakura, Yutaka</au><au>Yuda, Masamichi</au><au>Terada, Katsuhide</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Coformer Screening Using Thermal Analysis Based on Binary Phase Diagrams</atitle><jtitle>Pharmaceutical research</jtitle><stitle>Pharm Res</stitle><addtitle>Pharm Res</addtitle><date>2014-08-01</date><risdate>2014</risdate><volume>31</volume><issue>8</issue><spage>1946</spage><epage>1957</epage><pages>1946-1957</pages><issn>0724-8741</issn><eissn>1573-904X</eissn><abstract>ABSTRACT
Purpose
The advent of cocrystals has demonstrated a growing need for efficient and comprehensive coformer screening in search of better development forms, including salt forms. Here, we investigated a coformer screening system for salts and cocrystals based on binary phase diagrams using thermal analysis and examined the effectiveness of the method.
Methods
Indomethacin and tenoxicam were used as models of active pharmaceutical ingredients (APIs). Physical mixtures of an API and 42 kinds of coformers were analyzed using Differential Scanning Calorimetry (DSC) and X-ray DSC. We also conducted coformer screening using a conventional slurry method and compared these results with those from the thermal analysis method and previous studies.
Results
Compared with the slurry method, the thermal analysis method was a high-performance screening system, particularly for APIs with low solubility and/or propensity to form solvates. However, this method faced hurdles for screening coformers combined with an API in the presence of kinetic hindrance for salt or cocrystal formation during heating or if there is degradation near the metastable eutectic temperature.
Conclusions
The thermal analysis and slurry methods are considered complementary to each other for coformer screening. Feasibility of the thermal analysis method in drug discovery practice is ensured given its small scale and high throughput.</abstract><cop>Boston</cop><pub>Springer US</pub><pmid>24522816</pmid><doi>10.1007/s11095-014-1296-4</doi><tpages>12</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0724-8741 |
ispartof | Pharmaceutical research, 2014-08, Vol.31 (8), p.1946-1957 |
issn | 0724-8741 1573-904X |
language | eng |
recordid | cdi_proquest_journals_1559513369 |
source | MEDLINE; SpringerLink Journals - AutoHoldings |
subjects | Biochemistry Biomedical and Life Sciences Biomedical Engineering and Bioengineering Biomedicine Differential Thermal Analysis - methods Drug Combinations Drug Evaluation, Preclinical - methods Indomethacin - analysis Indomethacin - chemistry Medical Law Methods Pharmaceutical sciences Pharmacology/Toxicology Pharmacy Piroxicam - analogs & derivatives Piroxicam - analysis Piroxicam - chemistry Powder Diffraction - methods Research Paper X-Ray Diffraction |
title | Coformer Screening Using Thermal Analysis Based on Binary Phase Diagrams |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T13%3A56%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Coformer%20Screening%20Using%20Thermal%20Analysis%20Based%20on%20Binary%20Phase%20Diagrams&rft.jtitle=Pharmaceutical%20research&rft.au=Yamashita,%20Hiroyuki&rft.date=2014-08-01&rft.volume=31&rft.issue=8&rft.spage=1946&rft.epage=1957&rft.pages=1946-1957&rft.issn=0724-8741&rft.eissn=1573-904X&rft_id=info:doi/10.1007/s11095-014-1296-4&rft_dat=%3Cproquest_cross%3E3421337371%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1559513369&rft_id=info:pmid/24522816&rfr_iscdi=true |